Chung Jane
SEC CIK 1872398 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STRO | SUTRO BIOPHARMA, INC. | Pres AND COO | 21.3K | $10.0K | — | 27 | 2022-08-09 | 2026-03-04 |
Most active insiders at STRO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MATSUI CONNIE | Dir | $40.0K | — |
| 2 | Chow Gregory K. | CFO | $16.0K | — |
| 3 | Gerber Hans-Peter | CSO | $13.6K | — |
| 4 | Pauling David | GC, Chief Admin. Ofcr | $10.0K | — |
| 5 | Chung Jane | CEO, Dir | $10.0K | — |
Transactions 27
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-06 | 2026-03-04 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | CEO, Dir | F - Tax | $21.31 | -282 | 21.3K | -1% | -$6,009 |
| D | 2026-03-06 | 2026-03-04 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | CEO, Dir | M - OptEx | $0.00 | +788 | 21.6K | +4% | $0 |
| DM | 2026-03-03 | 2026-03-01+ | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | CEO, Dir | F - Tax | $20.52 | -4,050 | 15.8K | -20% | -$83.1K |
| DM | 2026-03-03 | 2026-03-01+ | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | CEO, Dir | M - OptEx | $0.00 | +10.9K | 14.6K | +300% | $0 |
| D | 2025-12-16 | 2025-12-12 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | CEO, Dir | F - Tax | $8.02 | -894 | 13.9K | -6% | -$7,170 |
| D | 2025-12-16 | 2025-12-12 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | CEO, Dir | M - OptEx | $0.00 | +2,500 | 14.8K | +20% | $0 |
| 2025-10-16 | 2025-10-15 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | CEO, Dir | P - Purchase | $0.8 | +12.5K | 122.8K | +11% | +$10.0K | |
| D | 2025-08-26 | 2025-08-09 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | CEO, Dir | M - OptEx | $0.00 | +18.8K | 117.1K | +19% | $0 |
| D | 2025-08-26 | 2025-08-09 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | CEO, Dir | F - Tax | $0.8 | -6,708 | 110.3K | -6% | -$5,366 |
| D | 2025-03-06 | 2025-03-04 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Pres AND COO | M - OptEx | $0.00 | +7,875 | 100.6K | +8% | $0 |
| D | 2025-03-06 | 2025-03-04 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Pres AND COO | F - Tax | $1.42 | -2,334 | 98.3K | -2% | -$3,314 |
| D | 2025-03-04 | 2025-03-01 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Pres AND COO | F - Tax | $1.59 | -9,450 | 92.8K | -9% | -$15.0K |
| DM | 2025-03-04 | 2025-03-01 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Pres AND COO | M - OptEx | $0.00 | +31.9K | 102.2K | +45% | $0 |
| D | 2024-12-03 | 2024-12-01 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Pres AND COO | F - Tax | $2.69 | -8,920 | 70.3K | -11% | -$24.0K |
| D | 2024-12-03 | 2024-12-01 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Pres AND COO | M - OptEx | $0.00 | +25.0K | 79.3K | +46% | $0 |
| D | 2024-08-13 | 2024-08-09 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Pres AND COO | F - Tax | $3.12 | -6,689 | 54.3K | -11% | -$20.9K |
| D | 2024-08-13 | 2024-08-09 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Pres AND COO | M - OptEx | $0.00 | +18.8K | 61.0K | +44% | $0 |
| D | 2024-03-06 | 2024-03-04 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Pres AND COO | M - OptEx | $0.00 | +7,875 | 44.4K | +22% | $0 |
| D | 2024-03-06 | 2024-03-04 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Pres AND COO | F - Tax | $4.79 | -2,209 | 42.2K | -5% | -$10.6K |
| D | 2024-03-05 | 2024-03-01 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Pres AND COO | M - OptEx | $0.00 | +6,875 | 38.6K | +22% | $0 |
| D | 2024-03-05 | 2024-03-01 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Pres AND COO | F - Tax | $4.95 | -2,038 | 36.5K | -5% | -$10.1K |
| D | 2023-08-11 | 2023-08-09 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Chief Commercial Off | M - OptEx | $0.00 | +18.8K | 38.2K | +96% | $0 |
| D | 2023-08-11 | 2023-08-09 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Chief Commercial Off | F - Tax | $4.22 | -6,483 | 31.7K | -17% | -$27.4K |
| D | 2023-03-07 | 2023-03-03 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Chief Commercial Off | M - OptEx | — | +7,875 | 22.6K | +53% | — |
| D | 2023-03-07 | 2023-03-03 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Chief Commercial Off | F - Tax | $5.79 | -3,211 | 19.4K | -14% | -$18.6K |
| D | 2022-08-10 | 2022-08-09 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Chief Commercial Off | F - Tax | $6.60 | -6,483 | 14.8K | -31% | -$42.8K |
| D | 2022-08-10 | 2022-08-09 | STRO | SUTRO BIOPHARMA, INC. | Chung Jane | Chief Commercial Off | M - OptEx | $0.00 | +18.8K | 21.2K | +750% | $0 |
Purchase Sale Sale after option exercise All abbreviations